Sofinnova Partners

Sofinnova Partners is a Paris-based life sciences specialist and one of Europe’s most established healthcare venture firms, with a long history of investing across biopharma, medtech, industrial biotech, and digital medicine. The firm operates dedicated strategies including its flagship biopharma fund, an MD Start medical device incubation strategy, an industrial biotech vehicle, and a digital medicine fund that targets software, AI, and data-driven health companies. Check sizes vary by strategy but commonly range from low single-digit millions in early commitments to commitments totaling fifteen to thirty million euros or more over the life of an investment when the firm follows on. The natural fit depends on which strategy you target, and founders should be specific in their outreach. Therapeutics teams should approach the biopharma practice; medical device founders the MD Start group; software and AI teams the digital medicine fund. Healthcare AI founders building clinical software, AI-driven diagnostics, or data infrastructure for biopharma R&D have a credible path here, while pure consumer wellness or non-clinical apps do not. Founders should expect rigorous, sector-fluent diligence with scientific and clinical advisors involved early. The best entry path is a warm introduction from a portfolio CEO, a European biotech banker, an academic medical center collaborator, or a strategic at a pharma or device company. Direct outreach via LinkedIn to a partner aligned with your strategy is also a credible path. Expect partner-track engagement and a long-horizon partnership orientation.